Inheritance of abnormal expression of SOS-like response in xeroderma pigmentosum and hereditary cancer-prone syndromes.
The time course of induction of SOS-like stress responses such as enhanced reactivation (ER) and enhanced mutagenesis (EM) has been investigated in UV-C-irradiated skin fibroblasts from a xeroderma pigmentosum (XP) family, using herpes simplex virus type 1 as a probe. Similar ER studies were performed in a Li-Fraumeni syndrome (LFS) family and in a family with a high incidence of breast, ovarian, and colon cancer. In two XP (complementation group B) patients, with a striking absence of skin tumors even at an age of >40 years, only induction of EM was observed, whereas ER was absent (XPER-). The ER- phenotype was inherited from the father, whereas cells from the mother exhibited normal expression of ER and EM. This suggests that the absence of ER is a hereditary trait that is not correlated with a repair-deficient phenotype. Abnormally high levels of ER were observed in UV-C-exposed skin fibroblasts from rive LFS patients. The inheritance of the ER response was studied in one LFS family. High levels of ER were observed only in cells derived from affected individuals carrying one mutated p53 allele, whereas cells from unaffected family members, carrying two wild-type p53 alleles, exhibited normal ER levels. This result shows that abnormally high levels of ER positively correlate with the occurrence of cancer in affected individuals from a LFS family. Interestingly, abnormally high levels of ER were observed in cells from afflicted as well as from unafflicted members of a family with a high incidence of breast, ovarian, colon, and stomach cancer. This suggests that these latter individuals have inherited a mutated, putative predisposing gene, resulting in abnormal expression of ER, but that cancer had not yet developed. The results indicate that the ER response can possibly be used as a prognostic marker to identify carriers in various hereditary cancer-prone syndromes at an early age.
Abrahams
P J
PJ
Laboratory for Molecular Carcinogenesis, Leiden University, The Netherlands.
Houweling
A
A
Cornelissen-Steijger
D M
DM
Arwert
F
F
Menko
F H
FH
Pinedo
H M
HM
Terleth
C
C
van der Eb
A J
AJ
D001943:Breast Neoplasms / Q000235:genetics*; D002478:Cells, Cultured; D004279:DNA, Viral / Q000235:genetics; D005260:Female; D016147:Genes, Tumor Suppressor; D018259:Herpesvirus 1, Human; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000235:genetics*; D010375:Pedigree; D013014:SOS Response, Genetics; D012878:Skin Neoplasms / Q000235:genetics; D014407:Tumor Cells, Cultured; D014983:Xeroderma Pigmentosum / Q000235:genetics*
D004279:DNA, Viral